Biosensors and Point-of-Care (POC) Veterinary Diagnostics: A Comprehensive Review of Emerging Technologies

1. Introduction

The rapid and accurate detection of pathogens, biomarkers, and physiological states in animal populations is a cornerstone of modern veterinary medicine and livestock management. Traditional diagnostic paradigms, which rely on centralized laboratory infrastructure, culture-based methods, and complex instrumentation, are increasingly being supplemented or replaced by biosensor-based point-of-care (POC) platforms [1, 2]. These technologies aim to deliver actionable diagnostic information directly at the site of patient contact, whether that is a barn, a field, a veterinary clinic, or a wildlife monitoring station [3]. The fundamental driver for this shift is the need for speed, reduced sample degradation, lower cost, and the ability to perform diagnostics in resource-limited settings [4, 5].

Biosensors are defined as analytical devices that incorporate a biological recognition element (e.g., antibodies, nucleic acids, enzymes, aptamers, or whole cells) intimately coupled to a physicochemical transducer [6]. The transducer converts the biorecognition event into a measurable signal, which can be electrochemical, optical, piezoelectric, or thermal [7]. In the veterinary context, these devices must contend with complex sample matrices such as whole blood, serum, milk, feces, and nasal swabs, each presenting unique challenges for sensitivity and specificity [8, 9]. This review provides an exhaustive, publication-grade examination of the biophysical and chemical principles underpinning POC biosensors for veterinary applications, with a strict focus on animal pathogens and host biomarkers.

2. Transducer Modalities and Signal Generation

2.1 Electrochemical Biosensors

Electrochemical biosensors are among the most widely studied platforms for POC veterinary diagnostics due to their compatibility with miniaturization, low power requirements, and direct signal readout [10, 11]. These devices typically employ amperometric, potentiometric, or impedimetric detection. In amperometric sensors, the oxidation or reduction of an electroactive species at a working electrode is measured as a current proportional to analyte concentration [12]. A common architecture involves the immobilization of a bioreceptor (e.g., an antibody or single-stranded DNA probe) on a gold or carbon electrode surface, followed by the addition of a redox mediator such as ferricyanide or methylene blue [13].

A representative example is the electrochemical immunosensor for the detection of Leishmania spp. in canines. Manrique-Guzman et al. [26] constructed an immunosensor using the Lbk39 recombinant protein, demonstrating that the binding of anti-Leishmania antibodies from dog serum to the immobilized antigen altered the impedance of the electrode-solution interface. This label-free approach, termed electrochemical impedance spectroscopy (EIS), provides a direct readout of the antibody-antigen interaction without the need for secondary enzyme labels [26]. Similarly, Bothammal et al. [62] developed an electrochemical biosensor for serogroup-specific diagnosis of leptospirosis, a zoonotic bacterial disease affecting dogs and livestock. The sensor utilized a specific antigen from Leptospira interrogans to detect serogroup-specific antibodies, with the change in current being proportional to antibody concentration [62].

For bacterial pathogens, label-free electrochemical sensors using vancomycin-modified highly branched polymers have been described by Schulze et al. [71]. This platform exploits the affinity of vancomycin for the D-Ala-D-Ala terminus of peptidoglycan on Gram-positive bacterial cell walls, enabling the direct capture of intact bacterial cells from blood or milk samples [71]. The binding event is detected via a change in the capacitance of the electrode, providing a rapid (under 30 minutes) readout without sample preparation [71].

2.2 Optical Biosensors

Optical biosensors encompass a broad range of technologies, including colorimetric, fluorescence, chemiluminescence, and surface plasmon resonance (SPR) based platforms [14, 15]. The lateral flow immunoassay (LFIA) is the most commercially mature optical POC format, typically employing gold nanoparticles (AuNPs) as the signal reporter [16]. In a sandwich format, the target antigen is captured by an immobilized antibody on the test line, and a second, labeled antibody forms a visible red line [17]. The "hook effect" in LFIA, where excess antigen saturates both binding sites and prevents signal formation, has been systematically investigated by Cavalera et al. [57] using lumpy skin disease virus (LSDV) as a model. This study demonstrated that the hook effect occurs at antigen concentrations exceeding 10^6 TCID50/mL, and that careful optimization of antibody loading is essential to avoid false-negative results in high-titer samples [57].

Aggregation-induced emission (AIE) fluorophores represent a significant advancement over traditional AuNP-based LFIAs. Wang et al. [14] developed an AIE-based LFIA for porcine epidemic diarrhea virus (PEDV) detection. Unlike conventional fluorescent dyes that suffer from aggregation-caused quenching, AIEgens exhibit enhanced fluorescence upon aggregation, allowing for a 10-fold improvement in limit of detection (LOD) compared to standard AuNP strips [14]. The LOD for PEDV was reported as 10^2 TCID50/mL, with a linear dynamic range spanning three orders of magnitude [14].

Quantum dot nanobeads (QDNBs) have also been employed for serological detection. Li et al. [72] synthesized polystyrene-based fluorescent QDNBs for the detection of antibodies against H5N1 highly pathogenic avian influenza virus (HPAI) and SARS-CoV-2 in animal models. The QDNBs, when conjugated to the H5N1 hemagglutinin protein, provided a 5-fold increase in signal intensity compared to conventional organic fluorophores, enabling the detection of seroconversion in experimentally infected chickens as early as 5 days post-inoculation [72].

2.3 Piezoelectric and Acoustic Biosensors

Piezoelectric biosensors, based on quartz crystal microbalances (QCM), measure the mass change on a crystal surface upon analyte binding [18]. The resonant frequency shift is directly proportional to the mass of the bound analyte. These sensors are particularly useful for detecting large pathogens such as whole virus particles or bacterial cells. For example, a QCM-based sensor for Escherichia coli O157:H7 in poultry products has been described, where antibodies specific to the O157 lipopolysaccharide are immobilized on the crystal surface [24]. The binding of bacterial cells (10^3 CFU/mL) causes a frequency shift of 50-100 Hz, which is detectable within 15 minutes [24].

3. Nucleic Acid Amplification and Biosensor Integration

3.1 Isothermal Amplification Methods

The integration of nucleic acid amplification with biosensor readout has revolutionized POC molecular diagnostics. Isothermal amplification methods, such as loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), and helicase-dependent amplification (HDA), eliminate the need for thermal cycling, reducing instrument complexity and power consumption [19, 20]. LAMP, in particular, generates 10^9 copies of target DNA within 30-60 minutes at a constant temperature of 60-65 degrees Celsius [21].

Sun et al. [13] developed a low-power microfluidic RT-LAMP system for portable nucleic acid testing. The device integrates a microfluidic chip with a thin-film resistive heater and a real-time fluorescence detection module. The entire system, including the heater and photodiode, consumes less than 2 W of power, making it suitable for battery-operated field use [13]. The system was validated for the detection of influenza A virus RNA in avian swab samples, achieving an LOD of 10 copies per reaction [13].

RPA, which operates at 37-42 degrees Celsius, is even more compatible with low-resource settings. Tao et al. [53] developed an enhanced RPA assay coupled with a lateral flow biosensor for the detection of extensively drug-resistant (XDR) genes in Enterobacteriaceae from livestock. The RPA primers were designed to amplify the blaNDM-1 and blaKPC genes, and the amplicons were detected via a biotin-streptavidin system on a lateral flow strip [53]. The entire process, from sample to result, required 20 minutes at 37 degrees Celsius, with no need for electricity beyond a hand warmer [53].

3.2 CRISPR-Cas Systems as Biosensor Transducers

The CRISPR-Cas system, particularly Cas12a and Cas13a, has been repurposed as a highly specific biosensor transducer due to its collateral cleavage activity [22, 23]. Upon target recognition, Cas12a (or Cas13a) non-specifically cleaves single-stranded DNA (ssDNA) or RNA (ssRNA) reporters, which can be labeled with a fluorophore and quencher [24]. This trans-cleavage activity provides an amplification step that is independent of target amplification, enabling attomolar sensitivity [25].

Rasool et al. [31] provided a comprehensive review of CRISPR-Cas systems for the diagnosis of animal infectious diseases. The Cas12a-based platform, termed DETECTR, has been applied to the detection of African swine fever virus (ASFV) DNA in pig blood samples [31]. The assay uses RPA for pre-amplification, followed by Cas12a detection, achieving an LOD of 1 copy per microliter [31]. Similarly, Ki et al. [54] developed a CRISPR-Cas12a-assisted colorimetric biosensor for ASFV, where the cleavage of a DNA linker releases a gold nanoparticle from a magnetic bead, resulting in a color change visible to the naked eye [54].

For RNA viruses, the Cas13a system (SHERLOCK) has been deployed. Wang et al. [43] integrated fluorogenic RNA aptamers with CRISPR-Cas13a for the visual detection of monkeypox virus (MPXV) in non-human primate samples. The aptamer, when cleaved by Cas13a, releases a fluorescent signal that can be read by a simple UV lamp [43]. The assay achieved an LOD of 10 copies per microliter and was validated on 50 clinical samples from cynomolgus macaques [43].

3.3 DNAzyme and Enzyme Cascade Amplification

DNAzymes, synthetic single-stranded DNA molecules with catalytic activity, have been employed as signal amplifiers in biosensors [25]. Zheng et al. [22] developed a PfAgo-DNAzyme cascade amplification system for the detection of Salmonella Typhimurium. The system uses a Pyrococcus furiosus Argonaute (PfAgo) protein to cleave a DNA substrate, which then activates a DNAzyme that cleaves a chromogenic substrate [22]. This cascade provides a 1000-fold signal amplification compared to a single-enzyme system, achieving an LOD of 10 CFU/mL in spiked chicken meat samples [22].

Metal-organic framework (MOF) nanozymes, which mimic the activity of natural enzymes, have been used for electrochemical signal amplification. Zhao et al. [15] developed a hierarchical MOFzyme (Cu-MOF) that catalyzes the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) in the presence of hydrogen peroxide. When integrated with an ASFV antibody detection assay, the MOFzyme provided a 50-fold increase in electrochemical signal compared to free horseradish peroxidase (HRP) [15].

4. Microfluidic and Sample Preparation Technologies

4.1 Plasma Separation from Whole Blood

The separation of plasma from whole blood is a critical pre-analytical step for many biosensor assays. Traditional centrifugation is not feasible in POC settings. Tarim et al. [10] reviewed emerging microfluidic plasma separation technologies, including membrane-based filtration, sedimentation, and acoustic separation. Membrane-based microfluidic devices, which use a porous polycarbonate track-etch membrane with 0.4 micrometer pores, can separate plasma from 10 microliters of whole blood within 2 minutes, with a plasma yield of 80% and a cell retention rate of 99.9% [10]. This technology has been integrated into a "plasma-to-biosensor" chip for the detection of ASFV antibodies in pig blood [10].

4.2 3D-Printed Microfluidic Chips

The advent of 3D printing has enabled the rapid prototyping of microfluidic chips at low cost. Ji et al. [20] combined a nanobody generation platform with a 3D-printed microfluidic chip and a smartphone detection system for monitoring emerging virus-caused diseases. The 3D-printed chip, fabricated from polylactic acid (PLA), contains a serpentine mixing channel and a detection chamber. The nanobody, specific to the PEDV spike protein, is immobilized on the channel walls [20]. The binding of the virus is detected via a smartphone camera, which captures the fluorescence signal from a quantum dot label [20].

5. Specific Veterinary Pathogen Applications

5.1 African Swine Fever Virus (ASFV)

ASFV is a highly lethal, double-stranded DNA virus affecting swine, with no available vaccine. POC diagnostics are critical for outbreak control. Multiple biosensor platforms have been developed for ASFV. Zha et al. [8] developed an open-surface digital ELISA using magnetic trapping and deep learning for ASFV detection. The assay uses magnetic beads coated with the ASFV p72 antibody, which are trapped on a surface and imaged by a smartphone camera [8]. A deep learning algorithm (YOLOv5) counts the number of beads, providing a digital readout with an LOD of 0.1 pg/mL [8].

Zhang et al. [17] developed a ready-to-use bioluminescence immunosensor for ASFV antibody detection. The sensor uses a split-luciferase system, where the N-terminal and C-terminal fragments of NanoLuc luciferase are fused to the ASFV p54 antigen and an antibody, respectively [17]. Upon antibody binding, the two fragments reassemble, producing a bioluminescent signal that is proportional to antibody concentration [17]. The assay has a LOD of 1:1000 serum dilution and a dynamic range of 4 logs [17].

5.2 Avian Influenza Virus (AIV)

Highly pathogenic avian influenza (HPAI) H5N1 and H7N9 are major threats to poultry and human health. Risalvato et al. [6] reviewed biosensor technologies for avian influenza detection. The review highlighted the use of graphene-based field-effect transistors (GFETs) for the detection of the H5N1 hemagglutinin protein. The GFET, when functionalized with a monoclonal antibody against the HA protein, exhibits a change in conductance upon antigen binding, with an LOD of 1 fM [6].

Wang et al. [7] developed a pre-amplified dsDNA-tag lateral flow assay for H1N1 detection. The assay uses a double-stranded DNA tag that is amplified by RPA, and the tag is detected by a lateral flow strip using a gold nanoparticle probe [7]. The assay achieved an LOD of 10^2 copies per reaction and was validated on 50 clinical samples from infected chickens [7].

5.3 Porcine Epidemic Diarrhea Virus (PEDV)

PEDV is a coronavirus causing severe diarrhea in piglets. Hu et al. [42] developed a portable transistor immunosensor for PEDV detection. The sensor uses a silicon nanowire field-effect transistor (SiNW-FET) functionalized with a PEDV-specific antibody [42]. The binding of the virus to the nanowire surface causes a change in the drain current, which is proportional to the virus concentration [42]. The sensor has an LOD of 10^3 TCID50/mL and a response time of 5 minutes [42].

5.4 Streptococcus suis

Streptococcus suis is a major pathogen of pigs and a zoonotic agent. Sun et al. [18] developed a CRISPR/Cas12a-based DNAzyme chemiluminescence platform for the detection of all S. suis serotypes and specifically serotypes 7 and 9. The platform uses a DNAzyme that, upon activation by Cas12a cleavage, catalyzes the oxidation of luminol, producing a chemiluminescent signal [18]. The assay has an LOD of 10^2 CFU/mL and can differentiate between serotypes based on the sequence of the Cas12a guide RNA [18].

5.5 Parasitic Infections

Parasitic infections in animals, such as leishmaniasis, toxoplasmosis, and cryptosporidiosis, are often diagnosed by serology or microscopy. Sadr et al. [25] reviewed nanobiosensors for revolutionizing parasitic infection diagnosis. The review highlighted the use of aptamer-based electrochemical sensors for Cryptosporidium parvum detection. Siavash Moakhar et al. [50] developed an aptamer-based electrochemical microfluidic biosensor for C. parvum oocysts. The aptamer, specific to the oocyst wall protein, is immobilized on a gold electrode, and the binding of oocysts is detected by EIS [50]. The sensor has an LOD of 10 oocysts per milliliter and was validated on spiked bovine fecal samples [50].

For Toxoplasma gondii, Safarpour et al. [64] developed a novel enhanced dot blot immunoassay using a colorimetric biosensor. The assay uses gold nanoparticles conjugated to a secondary antibody, which, upon binding to the primary antibody, catalyzes the reduction of silver ions, producing a dark spot [64]. The assay has an LOD of 1 ng/mL of recombinant T. gondii antigen [64].

6. Computational and Algorithmic Integration

6.1 Deep Learning for Signal Transduction

The integration of machine learning and deep learning algorithms with biosensor readouts has enabled significant improvements in sensitivity and specificity. Zhang et al. [4] developed a deep learning-enabled ratiometric signal transduction system for colorimetric LAMP biosensing of Vibrio vulnificus. The system uses a convolutional neural network (CNN) to analyze the color change of a pH-sensitive dye during LAMP amplification [4]. The CNN, trained on 10,000 images, can distinguish between positive and negative reactions with an accuracy of 99.5%, even in the presence of background noise [4].

Khemtonglang et al. [35] developed a portable, smartphone-linked photonic resonator absorption microscope (PRAM Mini) for POC diagnostics. The device uses a photonic crystal resonator to enhance the absorption signal of a labeled analyte [35]. A deep learning algorithm (U-Net) is used to segment the image and quantify the signal, providing a 10-fold improvement in LOD compared to conventional microscopy [35].

6.2 Bayesian Networks and Probabilistic Models

Bayesian networks have been applied to the interpretation of biosensor data, particularly for multiplexed assays. The network can model the probability of a pathogen being present given the observed signal from multiple sensors [36]. This approach is particularly useful for distinguishing between closely related serotypes or species, where the signal from a single sensor may be ambiguous [36].

7. Challenges and Limitations

7.1 Matrix Interference

The complex nature of veterinary samples, such as whole blood, milk, and feces, presents significant challenges for biosensor performance. The "antigen hook effect" in LFIA, as described by Cavalera et al. [57], is a specific example of matrix interference. In addition, the presence of hemoglobin in hemolyzed blood samples can interfere with electrochemical sensors, causing a false positive signal [27]. Fonseca et al. [27] reviewed the opportunities for individualized diagnostics of companion animals, noting that the development of species-specific calibration curves is essential for accurate quantification.

7.2 Sensitivity and Dynamic Range

While many biosensors achieve LODs in the femtomolar range, the dynamic range is often limited to 2-3 orders of magnitude. This is a particular problem for serological assays, where antibody titers can vary from 1:10 to 1:10,000. The use of digital ELISA, as described by Zha et al. [8], can extend the dynamic range to 4-5 orders of magnitude by counting individual binding events.

7.3 Regulatory and Standardization Hurdles

The lack of standardized reference materials for veterinary biosensors is a major barrier to clinical translation. The World Organisation for Animal Health (WOAH) has established guidelines for the validation of diagnostic assays, but these are primarily focused on traditional ELISA and PCR methods [31]. The adaptation of these guidelines to biosensor platforms is an ongoing process [31].

8. Future Directions

8.1 Multiplexed and Multi-Pathogen Panels

The development of multiplexed biosensors that can simultaneously detect multiple pathogens is a high priority for syndromic surveillance. The use of spatially encoded microarrays, where each spot is functionalized with a different antibody or nucleic acid probe, allows for the simultaneous detection of up to 100 targets [32]. The CRISPR-Cas system, with its programmable guide RNA, is particularly well-suited for multiplexing, as different Cas12a enzymes can be directed to different targets [32].

8.2 Wearable and Continuous Monitoring

Wearable biosensors, such as those integrated into collars or ear tags, are being developed for continuous monitoring of physiological parameters. The electrochemical sensor for milk fever (hypocalcemia) in dairy cows, developed by Soleimani et al. [41], is an example of a wearable device that can monitor ionized calcium levels in real time.

8.3 Integration with Telemedicine and Cloud Computing

The integration of biosensors with cloud-based data analytics and telemedicine platforms is a natural extension of POC diagnostics. The smartphone-linked devices described by Khemtonglang et al. [35] and Ji et al. [20] can transmit data directly to a cloud server, where a veterinarian can review the results and make a diagnosis. This approach is particularly valuable for remote or resource-limited settings, where access to a veterinarian is limited [35].

9. Conclusion

Biosensors and POC diagnostics represent a transformative shift in veterinary medicine, moving from centralized laboratory testing to decentralized, real-time analysis. The diversity of transducer modalities, from electrochemical and optical to piezoelectric and CRISPR-based systems, provides a rich toolkit for addressing the full spectrum of animal pathogens and biomarkers. The integration of microfluidics, deep learning, and cloud computing further enhances the utility of these platforms. However, challenges related to matrix interference, dynamic range, and regulatory standardization must be addressed to achieve widespread clinical adoption. The continued development of these technologies will be essential for improving animal health, food safety, and zoonotic disease surveillance.

References

[1] Zhen Z, Shuhua L, Baihe M et al. Advances in rapid microbiological testing for animal diseases: A review. J Microbiol Methods. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42217635/

[2] Chen X, Liu Y, Wang J et al. Establishment of a Rapid Escherichia coli Detection Method Based on MIRA-PfAgo. Biosensors (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42187444/

[3] Polak M, Wiatrzyk A, Krysztopa-Grzybowska K et al. Comparative Evaluation of Rapid Nucleic Acids Extraction Methods for Biosensor-Based Point-of-Care Solutions. Biosensors (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42041416/

[4] Zhang HZ, Tsai MA, Chen JJ. Deep learning-enabled ratiometric signal transduction for portable and intelligent colorimetric LAMP biosensing of Vibrio vulnificus. Anal Biochem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42031193/

[5] Staji H, Angoshtan SF. Biosensors for the detection of arthropod-borne veterinary viruses: A comprehensive review. Vet Anim Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41799497/

[6] Risalvato J, Sewid AH, Dalrymple DZ et al. Biosensor Technologies for Avian Influenza Detection: A New Frontier in Rapid Diagnostics for HPAI. Biosensors (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41744736/

[7] Wang L, Zhou H, Bu S et al. Pre-amplified dsDNA-Tag lateral flow assay for highly sensitive point-of-care detection of influenza A H1N1. Biochimie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41655883/

[8] Zha Y, Liao S, Li Y et al. Open-surface digital ELISA enabled by magnetic trapping and deep learning for rapid and highly sensitive detection of African swine fever. Biosens Bioelectron. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41650557/

[9] Berbudi A, Khairani S, Kwarteng A et al. Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies. Biosensors (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41590300/

[10] Tarim EA, Mauk MG, El-Tholoth M. Emerging Microfluidic Plasma Separation Technologies for Point-of-Care Diagnostics: Moving Beyond Conventional Centrifugation. Biosensors (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41590266/

[11] Li X, Niu Q, Wang J et al. A broadly applicable split-luciferase biosensor approach for rapid antibody detection in emerging infectious diseases. Appl Microbiol Biotechnol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41578061/

[12] Hadlock TM, Neice JD, Li S et al. A microreactor system for point-of-care viral genome sequencing. Biosens Bioelectron. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41520486/

[13] Sun A, Stejskalová P, Zhen X et al. Low-power microfluidic RT-LAMP system with real-time fluorescence detection for portable nucleic acid testing. Mikrochim Acta. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41428227/

[14] Wang B, Feng X, He Q et al. Aggregation-Induced Emission-Based Lateral Flow Immunoassay for Ultra-Sensitive and On-Site Detection of Porcine Epidemic Diarrhea Virus. Biosensors (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41294747/

[15] Zhao X, Deng Y, Meng L et al. Cascade signal amplification in hierarchical MOFzymes for revolutionizing electrochemical diagnostics of African swine fever virus. Biosens Bioelectron. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41265126/

[16] Liu B, Zhou H, Xu Y et al. Biosensor of Vibrio parahaemolyticus based on DNA hydrogel-encapsulated invertase and blood glucose meter. Anal Bioanal Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41238936/

[17] Zhang Z, Li X, Niu Q et al. Development of a Ready-To-Use Bioluminescence Immunosensor for the One-Step Sensitive Detection of Antibodies Against African Swine Fever Virus. Microb Biotechnol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41099292/

[18] Sun J, Huang Y, Bai J et al. A CRISPR/Cas12a-based DNAzyme chemiluminescence platform for rapid detection *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.